In spite of a con~siderable literature on sarcoid disease, very little has been written concerning alterations in pulmonary physiology produced by this condition. Baldwin, Cournand, and Richards (1) recently reported studies of pulmonary function in various fibroses of the lungs, including two proven and three presumed cases of sarcoid. However, no patient was included in their study if the residual volume of the lungs exceeded the predicted normal value.
In spite of a con~siderable literature on sarcoid disease, very little has been written concerning alterations in pulmonary physiology produced by this condition. Baldwin, Cournand, and Richards (1) recently reported studies of pulmonary function in various fibroses of the lungs, including two proven and three presumed cases of sarcoid. However, no patient was included in their study if the residual volume of the lungs exceeded the predicted normal value.
We have had the opportunity of studying pulmonary function in a group of ten patients with sarcoidosis. The clinical manifestations of the disease included involvement of lymph nodes, lungs, liver, skin and bone. The diagnosis was confirmed in each case by biopsy of a lymph node or cutaneous lesion. All had negative tuberculin skin test. Eight had demonstrable involvement of the lungs or of mediastinal lymph nodes (see Table I ). We are presenting the data obtained on these to illustrate a pattern of pulmonary impairment that may be found in this disease.
METHODS
Pulmonary function studies were performed on each patient when first seen and, in five patients, were repeated two months later. The following measurements were made:
1. Arterial blood was obtained with the patient at rest, breathing room air. Arterial pH was measured at 370 C. in a Cambridge closed glass electrode. The CO. content of whole blood was measured and CO2 pressure was calculated (2) . Arterial 02 content and capacity were measured (2) and 02 saturation was calculated after making appropriate corrections (3).
2. Intrapulmonary distribution of inspired 02 was studied by the single breath technic described by Fowler (4) and Comroe and Fowler (5) using the Lilly nitrogen and flow meters (6, 7) . Data were derived from analysis of curves obtained from a single maximal expiration following a single maximal inspiration of 02. Studies of intrapulmonary gas mixing were also made by the technic of Cournand and his associates (8), i.e., measurement of the N2 concentration in an alveolar gas sample delivered at the end of a seven-minute period of 02 inhalation.
3. Vital capacity, inspiratory capacity (maximum volume of gas that can be inspired from resting expiratory level, and expiratory reserve (maximum volume of gas that can be expired from the resting expiratory level) were measured separately on a Benedict-Roth spirometer; the maximum of three trials was recorded. Functional residual capacity (FRC-sum of RV and expiratory reserve) was determined by the open circuit method of Darling, Cournand, and Richards (9). Residual gas volume (RV) and total capacity (TC) were calculated from the above values.2 Maximal breathing capacity per minute (MBC) was determined by maximal voluntary hyperventilation for 15 seconds through low resistance valves and wide tubing. The expired gas was collected in a compensating Tissot spirometer of 140 L capacity. The maximum of three attempts was recorded. Respiratory rate, depth, and minute volume were measured while the resting patient breathed through a mouthpiece and valves into the Tissot spirometer.
All gas volumes were corrected to 37°C. 760 mm. Hg, saturated with water vapor. Predicted values for maximal breathing capacity were based on the regression formula of Baldwin, Cournand, and Richards (11) . The predicted values for lung volumes were derived from a composite summary of the literature, in which height and weight were the important variables.
RESULTS
The results of the pulmonary function tests are presented in Tables II-IV. A. Patients with hilar and mediastinal adenopathy. In three patients (0. H., B. S., and I. W., Table I ), radiologic studies demonstrated that the intrathoracic lesions were confined largely to enlargement of the hilar and mediastinal lymph nodes. In these, the physiological findings were essentially within the normal range except for a slightly reduced MBC in patient I. W. and low arterial 02 saturation in patient 0. H.
B. Patients with parenchymal involvement of the lungs. Five such patients were studied. Vital 2The terminology used in this paper is that proposed by Pappenheimer (10) . capacity was reduced significantly in three of the ing; the MBC was 56%o to 74%o of expected norfive; this was due largely to a diminution in the mal values. inspiratory capacity. Total lung capacity was less All had definite abnormality in the distribution than the predicted normal value only in patient of inspired gas to the alveoli as judged by the single J. W. In all five, residual volume was increased breath analysis (5), even though pulmonary nimarkedly; it varied from 160%o to 331% of the trogen elimination was normal in all five as judged predicted normal value. The RV/TC ratios were by the Cournand seven-minute test (8) . This emall abnormally high, 30%o to 65%o. The FRC was phasizes the greater accuracy and reliability of the also greater than normal in all. Thus the lungs single breath test as a measure of the uniformity were in a hyperinflated state at the end of both of distribution of inspired gas. The reasons for a forced and a normal expiration. All five had this are presented elsewhere (5); hyperventilation evidence of impairment in the mechanics of breath-during the seven-minute test was probably suffi- cient to mask the presence of the poorly ventilated fuse pulmoniry fibrosis specifically, and conseareas, clearly revealed by the single breath. quently included in her report only cases that fitted Only one patient, E. S., had pulmonary insuffi-her rigid criteria. On the other hand, we were ciency at rest for the oxygenating mechanism; studying patients who fitted rigid clinical criteria none had insufficiency so far as CO2 elimination for pulmonary sarcoidosis. The pathological diswas concerned. None had disabling dyspnea. turbance in all cases of sarcoidosis may well Apparently breathing could still be increased, be that of fibrosis, but as Spain (12) has pointed without severe discomfort, sufficiently to arterial-out, fibrotic lesions may occur predominantly ize the venous blood.
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in -one of five general regions in the lung: bronchiolar, interstitial, intra-alveolar, vascular DISCUSSION or pleural. In the cases reported by Baldwin, inThe data obtained in our studies differ strik-tra-alveolar or interstitial fibrosis must have been ingly from those reported by Baldwin, Cournand, the predominant lesion, leading to obliteration of and Richards (1) . Their patients with sarcoidosis some functional lung tissue and a decrease in lung had a mean decrease in residual volume and total volume. In our cases, the fibrosis must have been capacity, whereas ours had no consistent change in concentrated around bronchioles or air ducts, -so total capacity but a marked increase in residual as to produce residual hyperinflation quite similar volume. The discrepancy appears to lie entirely in to that reported by Beale, Fowler, and Comroe the selection of cases. Baldwin was studying dif-(13) in symptom-free patients with chronic 2. In three of these, the thoracic disease was confined primarily to hilar and mediastinal adenopathy; in these the function studies were essentially normal except for a decrease in maximum breathing capacity in one and a reduction of arterial 02 saturation in another.
3. In five, the intrathoracic lesions were primarily pulmonary in nature; consistent abnormalities found in these were: (a) abnormal intrapulmonary gas distribution as measured by the single breath test; (b) increase in the absolute and relative value for residual capacity (residual hyperinflation); (c) decrease in maximum breathing capacity.
4. Reasons are presented for attributing these changes to peribronchiolar fibrosis rather than to intra-alveolar or interstitial fibrosis or to emphysema of the destructive type.
